2016
Angiotensin II antagonism is associated with reduced risk for gastrointestinal bleeding caused by arteriovenous malformations in patients with left ventricular assist devices
Houston BA, Schneider AL, Vaishnav J, Cromwell DM, Miller PE, Faridi KF, Shah A, Sciortino C, Whitman G, Tedford RJ, Stevens GR, Judge DP, Russell SD, Rouf R. Angiotensin II antagonism is associated with reduced risk for gastrointestinal bleeding caused by arteriovenous malformations in patients with left ventricular assist devices. The Journal Of Heart And Lung Transplantation 2016, 36: 380-385. PMID: 28169115, DOI: 10.1016/j.healun.2016.12.016.Peer-Reviewed Original ResearchConceptsLeft ventricular assist deviceGastrointestinal bleedingAngiotensin II antagonismARB therapyVascular endothelial growth factorArteriovenous malformationsVentricular assist deviceAssist deviceAngiotensin receptor blocker therapyContinuous-flow Left Ventricular Assist DevicesAssociation of ACEIReceptor blocker therapyInternational normalized ratioRegression hazard modelGastrointestinal arteriovenous malformationsJohns Hopkins HospitalLogistic regression analysisRisk of AVMAngiotensin II SignalingEndothelial growth factorBlocker therapyRenal functionAdult patientsBlood pressureCardiomyopathy etiology
2014
Comparing 3-T multiparametric MRI and the Partin tables to predict organ-confined prostate cancer after radical prostatectomy
Gupta RT, Faridi KF, Singh AA, Passoni NM, Garcia-Reyes K, Madden JF, Polascik TJ. Comparing 3-T multiparametric MRI and the Partin tables to predict organ-confined prostate cancer after radical prostatectomy. Urologic Oncology Seminars And Original Investigations 2014, 32: 1292-1299. PMID: 24863013, DOI: 10.1016/j.urolonc.2014.04.017.Peer-Reviewed Original ResearchConceptsNegative predictive valuePositive predictive valueOrgan-confined prostate cancerExtracapsular extensionOC diseasePartin tablesRadical prostatectomyClinical stageProstate cancerPredictive valueMedian prostate-specific antigen levelProstate-specific antigen levelMultiparametric magnetic resonance imagingHigh negative predictive valueHigh positive predictive valueBiopsy Gleason scoreInstitutional review board approvalAvailable clinical parametersDigital rectal examinationSeminal vesicle invasionHigher prognostic accuracyProstate cancer treatmentReview board approvalMagnetic resonance imagingLogistic regression models
2013
Quantitative dynamic contrast-enhanced MRI of pelvic and lumbar bone marrow: effect of age and marrow fat content on pharmacokinetic parameter values.
Breault SR, Heye T, Bashir MR, Dale BM, Merkle EM, Reiner CS, Faridi KF, Gupta RT. Quantitative dynamic contrast-enhanced MRI of pelvic and lumbar bone marrow: effect of age and marrow fat content on pharmacokinetic parameter values. American Journal Of Roentgenology 2013, 200: w297-303. PMID: 23436875, DOI: 10.2214/ajr.12.9080.Peer-Reviewed Original ResearchAdipose TissueAdolescentAdultAgedAged, 80 and overAgingBone MarrowContrast MediaFemaleHumansLumbar VertebraeMagnetic Resonance ImagingMaleMeglumineMetabolic Clearance RateMiddle AgedOrgan SpecificityOrganometallic CompoundsPelvic BonesReproducibility of ResultsSensitivity and SpecificityTissue DistributionYoung Adult